Attorney James Gourley details the many legal issues surrounding the GLP-1 drug market and offers advice to companies on how ...

We expected miracles—what we got was a legal minefield. As GLP-1 drugs like Ozempic reshape bodies and bottom lines, a ...

Novo Nordisk AS (NVO) reports strong sales and profit growth, while addressing compounding challenges and expanding its ...

Eli Lilly is proving that being second but better can also pay. Zepbound, the American firm’s weight-loss jab, was approved ...

A study co-led by Indiana University School of Medicine researchers presents a potential new strategy to prevent or slow the ...